SCHEMBL427318

SCHEMBL427318

CCC(N)C(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL428684 1.00
SCHEMBL31470932 1.00
SCHEMBL427317 1.00
SCHEMBL28141431 1.00 SLC1A3 (0.42)
SCHEMBL28154143 1.00 SLC1A3 (0.42)
Bromide SCHEMBL8055537 0.97
Hydrochloric Acid SCHEMBL373444 0.97
Hydrochloric Acid SCHEMBL373445 0.97
Hydrochloric Acid SCHEMBL2715205 0.97
Methane SCHEMBL27758711 0.97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1051 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12633622-B2 Separator for secondary battery and secondary battery comprising same SAMSUNG SDI CO., LTD. (KR) 2026-05-19 US claimed
US-12497373-B2 Intermediate compounds used for preparing brivaracetam, preparation methods for intermediate compounds, and use SHANGHAI BOC CHEMICAL CO., LTD. (CN) 2025-12-16 US claimed
US-20250281668-A1 BIOLOGICAL POLYSACCHARIDE HYDROGEL, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF QINGDAO HEALTH OCEAN BIOPHARMACEUTICAL CO., LTD. (CN) 2025-09-11 US claimed
EP-4514796-A1 CDK INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS OnQuality Pharmaceuticals China Ltd. (CN) 2025-03-05 EP claimed
US-12221413-B2 Processes to produce brivaracetam SUZHOU PENGXU PHARMATECH CO. LTD. (CN) 2025-02-11 US claimed
EP-3873955-B1 AMINO ACID GRAFTED POLYMER WITH SOOT HANDLING PROPERTIES AFTON CHEMICAL CORP (US) 2024-12-04 EP claimed
CN-118994046-A Preparation method of bemat and application of bemat in tablet 重庆圣华曦药业股份有限公司 2024-11-22 CN claimed
CN-118791870-A Antibacterial transparent nylon composite material and preparation method and application thereof 浙江新力新材料股份有限公司 2024-10-18 CN claimed
US-20240343689-A1 SYNTHESIS OF BRIVARACETAM OPTIMUS DRUGS PRIVATE LIMITED (IN) 2024-10-17 US claimed
CN-110204453-B Preparation method and system of 2-aminobutanamide 上海东庚化工技术有限公司 2024-09-03 CN claimed
EP-0165919-B1 (R)-ALPHA-ETHYL-2-OXO-1-PYRROLIDINACETAMIDE U C B, S.A. (BE) 1989-08-09 EP claimed
US-4837224-A TREATING MEMORY DISORDERS UCB SOCIETE ANONYME (BE) 1989-06-06 US claimed
US-4837223-A ANTIISCHEMIC AGENTS UCB SOCIETE ANONYME (BE) 1989-06-06 US claimed
US-4705752-A Process for the enzymatic hydrolysis of D-α-amino-acid amides STAMICARBON B.V. (NL) 1987-11-10 US claimed
EP-0212550-A2 Substituted dipeptide amides G.D. Searle & Co. (US) 1987-03-04 EP claimed
CN-85105301-A (S)-preparation method of alpha-ethyl-2-oxo-1-pyrrolidine acetamide 1987-01-14 CN claimed
CN-85105307-A (R)-preparation method of alpha-ethyl-2-oxo-1-pyrrolidine acetamide 1987-01-14 CN claimed
EP-0179523-A1 Process for the enzymatic hydrolysis of D-alpha-amino-acid amides STAMICARBON B.V. (NL) 1986-04-30 EP claimed
EP-0165919-A1 (R)-alpha-ethyl-2-oxo-1-pyrrolidinacetamide U C B, S.A. (BE) 1985-12-27 EP claimed
EP-0162036-A1 (S)-alpha-ethyl-2-oxo-1-pyrrolidinacetamide U C B, S.A. (BE) 1985-11-21 EP claimed